NO168825C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-pyrrolidinyltio-1-azabicyklo (3.2.0) hept-2-en-2-karboksylsyrederivater - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-pyrrolidinyltio-1-azabicyklo (3.2.0) hept-2-en-2-karboksylsyrederivaterInfo
- Publication number
- NO168825C NO168825C NO891919A NO891919A NO168825C NO 168825 C NO168825 C NO 168825C NO 891919 A NO891919 A NO 891919A NO 891919 A NO891919 A NO 891919A NO 168825 C NO168825 C NO 168825C
- Authority
- NO
- Norway
- Prior art keywords
- pyrrolidinyltio
- azabicyclo
- hept
- preparation
- carboxylic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB888811237A GB8811237D0 (en) | 1988-05-12 | 1988-05-12 | 3-pyrrolidinylthio-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO891919D0 NO891919D0 (no) | 1989-05-11 |
| NO891919L NO891919L (no) | 1989-11-13 |
| NO168825B NO168825B (no) | 1991-12-30 |
| NO168825C true NO168825C (no) | 1992-04-08 |
Family
ID=10636779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO891919A NO168825C (no) | 1988-05-12 | 1989-05-11 | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-pyrrolidinyltio-1-azabicyklo (3.2.0) hept-2-en-2-karboksylsyrederivater |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4983596A (fr) |
| EP (1) | EP0341557A1 (fr) |
| JP (1) | JPH02204490A (fr) |
| CN (1) | CN1038645A (fr) |
| AU (1) | AU3402289A (fr) |
| DK (1) | DK230689A (fr) |
| FI (1) | FI892281A7 (fr) |
| GB (1) | GB8811237D0 (fr) |
| HU (1) | HU208013B (fr) |
| IL (1) | IL90191A0 (fr) |
| MX (1) | MX15990A (fr) |
| NO (1) | NO168825C (fr) |
| NZ (1) | NZ229071A (fr) |
| OA (1) | OA09419A (fr) |
| PT (1) | PT90527A (fr) |
| ZA (1) | ZA893479B (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8923844D0 (en) * | 1989-10-23 | 1989-12-13 | Fujisawa Pharmaceutical Co | Carbapenem compounds |
| GB9103034D0 (en) * | 1991-02-13 | 1991-03-27 | Fujisawa Pharmaceutical Co | Processes for preparing carbapenem derivatives |
| US5360798A (en) * | 1991-07-04 | 1994-11-01 | Shionogi Seiyaku Kabushiki Kaisha | Aminooxypyrrolidinylthiocarbapenem compounds |
| JP3367104B2 (ja) * | 1992-04-13 | 2003-01-14 | 藤沢薬品工業株式会社 | 抗菌剤としての置換された3−ピロリジニルチオ−カルバペネム化合物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4552873A (en) * | 1981-08-19 | 1985-11-12 | Sankyo Company Limited | Carbapenem compounds, and compositions containing them |
| JPS5916892A (ja) * | 1982-07-19 | 1984-01-28 | Sankyo Co Ltd | カルバペネム−3−カルボン酸誘導体およびその製法 |
| KR900006449B1 (ko) * | 1982-08-24 | 1990-08-31 | 상꾜 가부시끼가이샤 | 아제티디논 화합물의 제조방법 |
| CA1283906C (fr) * | 1983-05-09 | 1991-05-07 | Makoto Sunagawa | COMPOSE DE .beta.-LACTAM ET PROCEDE DE PRODUCTION |
| JPS60202886A (ja) * | 1984-03-27 | 1985-10-14 | Sankyo Co Ltd | 1―置換カルバペネム―3―カルボン酸誘導体 |
| CA1281720C (fr) * | 1984-11-08 | 1991-03-19 | Makoto Sunagawa | Composes de carbapenem et leur production |
| EP0243686B1 (fr) * | 1986-03-27 | 1992-07-15 | Sumitomo Pharmaceuticals Company, Limited | Dérivés de bêta-lactame et leur préparation |
| KR880006244A (ko) * | 1986-11-24 | 1988-07-22 | 후지사와 도모 기찌 로 | 3-피롤리디닐티오-1-아자바이스클로[3.2.0]햅트2-엔-2-카르복실산 화합물 및 이의 제조방법 |
-
1988
- 1988-05-12 GB GB888811237A patent/GB8811237D0/en active Pending
-
1989
- 1989-05-03 EP EP89107967A patent/EP0341557A1/fr not_active Withdrawn
- 1989-05-04 US US07/347,025 patent/US4983596A/en not_active Expired - Fee Related
- 1989-05-04 IL IL90191A patent/IL90191A0/xx unknown
- 1989-05-04 AU AU34022/89A patent/AU3402289A/en not_active Abandoned
- 1989-05-10 NZ NZ229071A patent/NZ229071A/en unknown
- 1989-05-10 MX MX1599089A patent/MX15990A/es unknown
- 1989-05-10 ZA ZA893479A patent/ZA893479B/xx unknown
- 1989-05-11 FI FI892281A patent/FI892281A7/fi not_active Application Discontinuation
- 1989-05-11 DK DK230689A patent/DK230689A/da not_active Application Discontinuation
- 1989-05-11 PT PT90527A patent/PT90527A/pt not_active Application Discontinuation
- 1989-05-11 HU HU892369A patent/HU208013B/hu not_active IP Right Cessation
- 1989-05-11 NO NO891919A patent/NO168825C/no unknown
- 1989-05-12 JP JP1119141A patent/JPH02204490A/ja active Pending
- 1989-05-12 OA OA59575A patent/OA09419A/fr unknown
- 1989-05-12 CN CN89103171A patent/CN1038645A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| OA09419A (fr) | 1992-10-15 |
| FI892281A0 (fi) | 1989-05-11 |
| CN1038645A (zh) | 1990-01-10 |
| HU208013B (en) | 1993-07-28 |
| MX15990A (es) | 1993-09-01 |
| NO891919L (no) | 1989-11-13 |
| ZA893479B (en) | 1990-01-31 |
| GB8811237D0 (en) | 1988-06-15 |
| FI892281A7 (fi) | 1989-11-13 |
| PT90527A (pt) | 1989-11-30 |
| NZ229071A (en) | 1990-08-28 |
| HUT50476A (en) | 1990-02-28 |
| NO168825B (no) | 1991-12-30 |
| DK230689D0 (da) | 1989-05-11 |
| NO891919D0 (no) | 1989-05-11 |
| IL90191A0 (en) | 1989-12-15 |
| JPH02204490A (ja) | 1990-08-14 |
| DK230689A (da) | 1989-11-13 |
| AU3402289A (en) | 1989-11-16 |
| EP0341557A1 (fr) | 1989-11-15 |
| US4983596A (en) | 1991-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO883974L (no) | Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater. | |
| NO894630D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater. | |
| NO882732L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
| NO171787C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-azabicyclo(3.2.1)oct-2-en-forbindelser | |
| NO864425D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklyloksoftalazinyl-eddiksyre-derivater. | |
| NO880182L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,2-dihydro-3h-indazol-3-on-derivater. | |
| NO893270D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridineddiksyrederivater. | |
| NO167916C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiolaktam-n-eddiksyrederivater | |
| NO171412C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater | |
| NO883122D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater. | |
| NO870049L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
| NO890155D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser. | |
| NO891114D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater. | |
| NO891723L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
| NO167802C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater. | |
| NO170930C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-okso-3-kinolinkarboksylsyrer | |
| NO168825C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-pyrrolidinyltio-1-azabicyklo (3.2.0) hept-2-en-2-karboksylsyrederivater | |
| NO172491C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater | |
| NO168247C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-metoksy-alkyl-ammonium-tetrahydrofuraner. | |
| NO171499C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6-dihydro-4h-cyklo-penta(b)tiofen-6-karboksylsyre-derivater | |
| NO167511C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater. | |
| NO890724D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater. | |
| NO863005D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater. | |
| NO890519D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive propanon-derivater. | |
| NO170541C (no) | Analogiframgangsmaate for framstilling av terapeutisk aktive 1,5-benzotiazepinderivater |